Billede af Ole Jannik Bjerrum

Ole Jannik Bjerrum

Læge

 https://orcid.org/0000-0002-1085-8444
1979 …2019

Publikationer pr. år

Netværk

Anne-Marie Heegaard

Person

Trine Meldgaard Lund

Person

George Gegelashvili

Person

Mogens Holst Nissen

Person

Marie Louise (Marieke) De Bruin

Person

Jens Lykkesfeldt

Person

Lotte Stig Nørgaard

Person

Majid Sheykhzade

Person

Kristoffer Lihme Egerod

Person

Ulrik Westrup

Person

Mette Berendt

Person

Helle Wallach Kildemoes

Person

Theis Lange

Person: TAP

Morten Jannik Bjerrum

Person: VIP

Rikke Rie Hansen

Person

Laila Eljaja

  • Institut for Farmakologi og Farmakoterapi

Ekstern person

Merete Schmiegelow

  • NovoNordisk A/S

Ekstern person

Malcolm Rowland

  • University of Manchester

Ekstern person

K.K. Frederiksen

Ekstern person

Mikael Thomsen

  • Conrig Pharma A/S

Ekstern person

Yvonne Gautam

  • NovoNordisk A/S

Ekstern person

Pernille Kristensen

  • Institut for Farmakologi og Farmakoterapi

Ekstern person

A. Nykjær

Ekstern person

Gordon Munro

  • Neurosearch
  • H. Lundbeck A/S

Ekstern person

P. Kristensen

Ekstern person

Mette Richner

  • Aarhus University

Ekstern person

Y. Gautam

Ekstern person

Pia Møllgaard

  • Institut for Farmakologi og Farmakoterapi

Ekstern person

M. Schmiegelow

Ekstern person

B. Abrahamsen

Ekstern person

L. Thyregod

Ekstern person

Colin Garner

Ekstern person

Richard John Weaver

  • Servier Group,

Ekstern person

Lene Munkholm Andersen

  • Institut for Farmakologi og Farmakoterapi

Ekstern person

Ming Ding

  • University of Southern Denmark

Ekstern person

S. H. Ingwersen

Ekstern person

J. Brian Houston

  • Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester

Ekstern person

Roeline Jochemsen

  • Servier Group

Ekstern person

Christian B. Vaegter

  • Aarhus University

Ekstern person

Andreas Hald

  • FARMA

Ekstern person

Peter Thygesen

  • Novo Nordisk A/S (Biz)

Ekstern person

Stephen Butler

  • Pain clinic, Department of anesthesiology and intensive care, University of Uppsala, Sweden

Ekstern person

Jørgen Dirac

  • NovoNordisk A/S

Ekstern person

Hans J. Bjerrum

  • Psychiatry Practice

Ekstern person

T.S. Jensen

Ekstern person

Erik Dupontd

  • Aarhus University

Ekstern person

Berend Oosterhuis

  • PRA International BV, P.O. Box 200, 9470 AE Zuidlaren, The Netherlands

Ekstern person

Yoko Shishikura

  • Xceleron Ltd.

Ekstern person

Athanasia Boulakou

  • Department of Drug Design and Pharmacology

Ekstern person

F. Larsen

Ekstern person

Møllgaard P.

Ekstern person

Anders Nykjær

  • Aarhus University

Ekstern person

Richard John Weaver

  • Servier Research Institute

Ekstern person

Majbritt Larsen

  • Institut for Lægemiddeldesign og Farmakologi

Ekstern person

Signe Wilsbech

Ekstern person

Lene Munkholm Neustrup

  • Institut for Farmakologi og Farmakoterapi

Ekstern person

G. Gegelashvili

Ekstern person

C. V. Bjerregaard

Ekstern person

Cathrine Jespersgaard

Ekstern person

Y De Koninck

Ekstern person

Jan Wiese

  • Martin Luther University Halle-Wittenberg

Ekstern person

Frederik Rode

  • Det Farmaceutiske Fakultet, Københavns Universitet

Ekstern person

Frank Larsen

  • H. Lundbeck A/S

Ekstern person

H.B. Hove

Ekstern person

Christian B Vaegter

Ekstern person

Stine G. Jørgensen

  • FARMA

Ekstern person

R D Jeggo

Ekstern person

Kim K Kristensen

  • NovoNordisk A/S, Copenhagen

Ekstern person

Signe Neustrup

  • Institut for Farmakologi og Farmakoterapi

Ekstern person

K B Helle

Ekstern person

Vasiliki Vana

  • Systenmsd pharmacology, Dept drug design and pharmacology, Univ Copenhagen

Ekstern person

Arafat Nasser

Ekstern person

Niels H. H. Heegaard

  • Statens Serum Institut

Ekstern person

Yvonne Gautam

  • Department of Drug Design and Pharmacology

Ekstern person

Niels HH Heegaard

  • Statens Serum Institut

Ekstern person

T Plesner

Ekstern person

Troels Staehelin Jensen

  • Aarhus University

Ekstern person

M Wilken

Ekstern person

Marc Jochimsen

  • Universität Konstanz

Ekstern person

Georgi Gegelashvili

Ekstern person

C. Dali

Ekstern person

Berend Oosterhuis

  • PRA International BV

Ekstern person

Brian Houston

  • University of Manchester

Ekstern person

Rajesh Krishna

  • Merck Research Laboratories

Ekstern person

A.T. Møller

Ekstern person

Daan J.A. Crommelin

  • Top Institute Pharma

Ekstern person

Gösta Nachman

Ekstern person

Ann Merry

  • University of Copenhagen

Ekstern person

L. Callesen

Ekstern person

Heidi Foth

  • Martin Luther University Halle-Wittenberg

Ekstern person

Graham Lappin

  • Xceleron Ltd.

Ekstern person

Colin Garner

  • Xceleron Ltd.

Ekstern person

T.E. Gordh

Ekstern person

L Jessen

Ekstern person

P. Thygeson

Ekstern person

Hans H. Linden

  • European Federation for Pharmaceutical Sciences

Ekstern person

Anna Basnet

  • Department of Drug Design and Pharmacology

Ekstern person

Gordon Blackburn-Munro

  • Neurosearch A/S, Ballerup

Ekstern person

B. Møller

Ekstern person

Troels S. Jensen

  • Aarhus University Hospital /Aarhus Universitetshospital

Ekstern person

Margareta Butler

  • Pain clinic, Department of anesthesiology and intensive care, University of Uppsala, Sweden

Ekstern person

M. Butler

Ekstern person

Anette T. Møller

  • Aarhus University Hospital /Aarhus Universitetshospital

Ekstern person

Kim Kristensen

  • Novo Nordisk A/S (Biz)

Ekstern person

Louise S. Dalbøge

  • Institut for Lægemiddeldesign og Farmakoloig
  • Novo Nordisk Foundation

Ekstern person

Lisbeth Birk Møller

  • Institut for Natur, Systemer og Modeller

Ekstern person

N. Toft

Ekstern person

Helle Angelo

Ekstern person

Baris Atalay

  • FARMA

Ekstern person

Monika Androlyte

Ekstern person

Tine Broløs

  • Det Farmaceutiske Fakultet, Københavns Universitet

Ekstern person

Sawsan Ali

Ekstern person

Mads Thomsen

  • Det Farmaceutiske Fakultet, Københavns Universitet

Ekstern person

Yvonne Gautam

  • Systems pharmacology, Dept Drug design and pharmacology, University of Copenhagen

Ekstern person

Pernille Kristensen

  • University of Copenhagen

Ekstern person

Merete Schmiegelow

  • Novo Nordisk A/S (Biz)

Ekstern person

Vasiliki Vana

  • University of Copenhagen

Ekstern person

S. Butler

Ekstern person

Vibe Hellmund

  • Aarhus University

Ekstern person

Jane Alder

  • University of Manchester

Ekstern person

Yoko Shishikura

  • Xceleron Ltd.

Ekstern person

Steen H Ingwersen

  • Novo Nordisk A/S (Biz)

Ekstern person

S. Neustrup

Ekstern person

Dominik Sawicki-Wrzask

Ekstern person

Grzegorz Grynkiewicz

  • Pharmaceutical Research Instiut

Ekstern person

Sanja Dragovic

  • Vrije Universiteit Amsterdam

Ekstern person

Anette Torvin Møller

  • Aarhus University

Ekstern person

B Johansen

Ekstern person

Lene Munkholm Andersen

Ekstern person

Torsten E Gordh

  • Pain clinic, Department of anesthesiology and intensive care, University of Uppsala, Sweden

Ekstern person

Sidsel Salling Thorborg

  • University of Copenhagen

Ekstern person

Charlotte Gesson

  • Servier Research Institute

Ekstern person

K. Kristensen

  • Novo Nordisk A/S (Biz)

Ekstern person

Lisbeth Birk Møller

  • University of Copenhagen

Ekstern person

Graham Lappin

  • Xceleron Ltd.

Ekstern person

K. Kristensen

Ekstern person

L. B. Møller

Ekstern person

Hans Guenter Schaefer

  • Boehringer-Ingelheim Pharma GmbH & Co. KG

Ekstern person

Chris Vos

  • Vrije Universiteit Amsterdam

Ekstern person

Niels Westergaard

Ekstern person

Dorthe Konradsen

  • FARMA

Ekstern person

Søren Troels Christensen

Ekstern person

Lisbeth B. Møller

  • Copenhagen University Hospital

Ekstern person

Lisbeth Birk Møller

Ekstern person

Roeline Jochemsen

  • Servier Research Institute

Ekstern person

Charlotte Gesson

  • Servier Group

Ekstern person

G. Ludvig

Ekstern person

N Alkis

Ekstern person

Erik Dupont

  • Aarhus University Hospital /Aarhus Universitetshospital

Ekstern person